Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Neil Mabbott, Personal Chair of Immunopathology, The University of Edinburgh

Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK

The Sanofi vaccine is the seventh COVID vaccine to be approved for use in the UK. Vladimka production/Shutterstock

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to get their next shot.

For some this will be their sixth dose to date. But as immunity from COVID vaccines begins to wane in the months afterwards, this is a sensible precaution to help protect the most vulnerable against serious illness, hospitalisation and death should they contract the virus.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.